To assess in humans whether GAL@ stimulates breathing in established opioid-induced respiratory depression and to evaluate its safety , a proof-of-concept double-blind randomized controlled crossover study on isohypercapnic ventilation ( study @ ) and subsequent double-blind exploratory study on poikilocapnic ventilation and nonrespiratory end points ( study @ ) was performed .